STOCK TITAN

AvePoint, Inc. SEC Filings

AVPT NASDAQ

Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.

Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.

Rhea-AI Summary

AvePoint (AVPT) reported insider transactions by its Chief Executive Officer and Director on 10/13/2025. The reporting person exercised stock options (transaction code M) and acquired common stock (coded A) at an exercise price of $14.61 per share in three tranches of 569,707, 362,850, and 1,716,047 shares. Following these transactions, the reporting person directly beneficially owned 3,200,238 shares. The filing notes these holdings include vested and unvested RSUs granted under the company’s equity plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

AvePoint, Inc. (AVPT) director and Executive Chairman Gong Xunkai reported two scheduled stock sales under a Rule 10b5-1 trading plan adopted on 06/22/2025. On 10/06/2025 he sold 55,833 shares at $15.31, and on 10/07/2025 he sold 4,167 shares at $15.08. After these transactions he is reported to beneficially own 15,100,668 shares held indirectly through several trusts and LLCs for which he serves as trustee or is an affiliate.

The filing notes the sales were effected pursuant to the pre-established trading plan and disclaims direct beneficial ownership of trust and LLC holdings except to the extent of pecuniary interest. The form was signed by an attorney-in-fact on 10/08/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.04%
Tags
insider
-
Rhea-AI Summary

AvePoint, Inc. director and Executive Chairman Xunkai Gong reported a sale of 31,950 shares of common stock on 09/29/2025 at $15.34 per share under a Rule 10b5-1 trading plan adopted on 06/22/2025. The filing shows Mr. Gong beneficially owns 15,188,718 shares following the sale, held indirectly through several trusts and LLCs (Giocoso Holdings LLC, Cadenza Holdings LLC, Vivace Holdings LLC, The Purple Harbor Trust, The Purple Cove Trust, and G Sonata Trust). The report states he disclaims beneficial ownership of trust/LLC shares except to the extent of his pecuniary interest.

The transaction was reported on Form 4 and was executed pursuant to a pre-established trading plan, indicating the sale was planned rather than opportunistic based on undisclosed material information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A holder of AvePoint, Inc. (AVPT) filed a Form 144 announcing a proposed sale of 240,000 Common Class A shares through The Charles Schwab Corporation. The filing lists an aggregate market value of $3,705,600 and shows approximately 211,926,808 shares outstanding, with an approximate sale date of 09/29/2025 on NASDAQ. The shares were acquired as founders shares from the issuer on 01/02/2006, and the filer reports no securities sold in the past three months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

AvePoint, Inc. insider sale of 35,000 common shares executed under a Rule 10b5-1 plan. The reporting person, Brian Michael Brown, who serves as Chief Legal Officer and a director, reported three sales totaling 35,000 shares on 09/23/2025 at prices between $15.49 and $15.59 per share. Following these transactions the filing shows beneficial ownership reported in the ranges of 650,474 down to 633,741 shares across the reported lines, which the filer states includes both non-RSU common stock and aggregate vested and unvested RSUs subject to previously reported vesting schedules. The filing notes the sales were made pursuant to a 10b5-1 trading plan adopted December 18, 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AvePoint, Inc. (AVPT) Form 4 summary: The company’s Chief Legal Officer and director, Brian Michael Brown, reported two transactions in September 2025. On 09/19/2025 he had 1,547 shares disposed at $15.67 each, identified as withholding of shares to satisfy tax obligations upon vesting. On 09/22/2025 he reported a 30,000-share acquisition tied to the exercise of stock options (exercise price $1.3357) with a reported price of $15.75. Following these transactions, the filing shows 668,741 shares of common stock directly held and an aggregate beneficial ownership of 2,286,102 shares (including derivative securities and RSUs).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Jiang Tianyi, who serves as Chief Executive Officer and a director of AvePoint, Inc. (AVPT), reported a transaction on 09/19/2025 in which 4,706 shares of common stock were disposed of at $15.67 per share. The filing states this disposition was an exempt, non-discretionary transaction consisting of shares withheld by the company to satisfy income tax withholding obligations related to the net settlement of vested restricted stock units (RSUs). After the withholding, the reporting person beneficially owned 551,634 shares, which includes both non-RSU common stock and vested and unvested RSUs previously reported. The transaction was signed by an attorney-in-fact on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AvePoint director and Executive Chairman Gong Xunkai reported a transaction on 09/19/2025 relating to the company’s common stock and restricted stock units under the 2021 Equity Incentive Plan. The filing shows 6,500 shares were disposed of at an effective price of $15.67 in an exempt transaction where shares were withheld to satisfy tax withholding obligations on RSU vesting. After the withholding, the reporting person beneficially owned 763,702 shares (including vested and unvested RSUs). The Form 4 was signed by an attorney-in-fact on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Caci James, AvePoint (AVPT) Chief Financial Officer, reported a withholding of 2,823 shares on 09/19/2025 at a price of $15.67 per share to satisfy tax obligations related to vested restricted stock units (RSUs). The filing states this was an exempt, non‑discretionary transaction consisting of delivery/withholding of shares to pay taxes in connection with RSU vesting. Following the transaction, the reporting person beneficially owns 210,207 shares, which includes vested and unvested RSUs held under previously reported grant schedules.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AvePoint, Inc. (AVPT) filing reports a proposed sale of 35,000 common shares through Rockefeller Financial with an aggregate market value of $543,633.74, with an approximate sale date of 09/23/2025. The shares were originally received as a restricted stock grant on 07/07/2022 and were granted as compensation. The issuer has 211,926,808 shares outstanding. The filer previously sold three blocks of 35,000 shares on 06/23/2025, 07/23/2025 and 08/25/2025, with gross proceeds shown for each transaction. The notice includes the standard representation regarding absence of undisclosed material information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many AvePoint (AVPT) SEC filings are available on StockTitan?

StockTitan tracks 106 SEC filings for AvePoint (AVPT), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AvePoint (AVPT)?

The most recent SEC filing for AvePoint (AVPT) was filed on October 15, 2025.